Ebony Hoskins, MDGynecologic Oncology, Gynecology, Gynecological Surgery
- Gynecologic Oncology
Areas of Expertise
- Abnormal Pap Smear/Abnormal Bleeding
- Obesity in Relationship with Gyn Cancers
- Ovarian Masses
- Robotic/Laparoscopic Surgery
Magee-Women’s Hospital Pittsburgh
PA Gyn Oncology
St. Joseph-Mercy Hospital
Ann Arbor, MI
Wayne State University School of Medicine
Doctor of Medicine
Xavier University of Louisiana
Bachelor of Science
New Orleans, LA
Hospitals Affiliated With
Holy Cross Hospital
Holy Cross Hospital Germantown
Shady Grove Adventist
In her spare time, Dr. Hoskins loves traveling, working out, photography, and laughing with family and friends.
Dr. Ebony Hoskins is a board certified gynecologic oncologist from Michigan. At a young age, she determined she wanted to pursue a career in medicine. She attended the Xavier University of Louisiana, with this goal in mind. After Xavier, Dr. Hoskins matriculated at Wayne State University School of Medicine and completed her residency in gynecology at St. Joseph-Mercy Hospital in Ann Arbor, MI.
While pursuing her interests in gynecologic oncology, she chose to enhance herself and skills, after her residency, by completing a Cancer Research Training Award (CRTA) at the National Cancer Institute (NCI). Dr. Hoskins had an enlightening experience studying the molecular mechanisms behind the malignant potential of ovarian cancer cells. After her time at the NCI, Dr. Hoskins entered a clinical fellowship in Gynecologic Oncology at Magee-Women’s Hospital in Pittsburgh, PA.
Prior to her arrival here at Women’s Health Specialists, Dr. Hoskins practiced gynecologic oncology for 3 years in Grand Rapids, MI. There she honed her surgical skills in gynecologic malignancies and complex gynecologic surgical problems while completing over 200 robotic assisted surgeries. Dr. Hoskins has taken a special interest in the subfield of obesity and cancer due to its direct relationship in the development of endometrial cancer and cancer disparities as it relates to African-American women with endometrial cancer.